Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...
He was born with HIV. She is HIV-negative, but she chose to love him. However, as the US pulls back crucial funding for ARVs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback